FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and pharmaceutics and concerns combined anti-tuberculosis composition in form of solid medicinal form including as active components riphampicin, levofloxacin, isoniazide, pyrazinamide and pyridoxine hydrochloride.
EFFECT: increased treatment efficiency.
8 cl, 1 tbl, 6 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 | 
 | RU2478389C2 | 
| COMPOSITE PHARMACEUTICAL COMPOSITION WITH ANTITUBERCULOUS ACTIVITY | 2003 |  | RU2247561C1 | 
| COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |  | RU2247560C1 | 
| ANTITUBERCULOUS AGENT | 2003 |  | RU2247559C1 | 
| COMBINED ANTITUBERCULOUS DRUG AND METHOD FOR PREPARING THEREOF | 2008 | 
 | RU2431487C2 | 
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 | 
 | RU2430724C2 | 
| COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | 2009 | 
 | RU2422145C2 | 
| COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |  | RU2182483C1 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 | 
 | RU2413517C1 | 
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 | 
 | RU2468802C2 | 
Authors
Dates
2009-05-10—Published
2007-07-09—Filed